To evaluate the role of EUS-FNA in abdominal lymphadenopathy.
Prospective study conducted over 42 months.
Tertiary care center in New Delhi, India.
Patients with abdominal lymphadenopathy in whom image-guided node biopsy failed were considered for EUS-FNA.
A total of 3 passes were performed at each site. Slides were prepared per protocol and sent for cytopathologic evaluation.
A total of 142 patients were enrolled, but only 130 (91.5%) underwent FNA. The mean lymph node size was 22 卤 3.2 mm; 71.8%of the nodes were hypoechoic (n = 102), and 28.1%were heterogeneous with an anechoic center (n = 40). In 120 patients (84.5%), the lymph nodes were intra-abdominal only, and in 22 patients (15.5%), they were both intra-abdominal and mediastinal in location.
EUS-FNA was successful in establishing a diagnosis in 90.8%of these patients; 76.1%were found to have tuberculosis, 7.04%sarcoidosis, 6.33%Hodgkin's lymphoma, and 0.74%non-Hodgkin's lymphoma.
In 8.4%patients, nodes were inaccessible because of their retropancreatic location.
EUS-FNA is a safe, accurate, and minimally invasive modality for diagnosing the cause of abdominal lymphadenopathy. In highly endemic areas, tuberculosis is the most common cause.